You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIB melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

Completed
Has Results
  • Unresectable Stage IIIB-IV Malignant Melanoma
  • Talimogene laherparepvec
  • Nagoya-shi, Aichi, Japan
  • +8 more
Jan 13, 2023

Melanoma Trial in Wollstonecraft, Cairns (tigilanol tiglate)

Recruiting
  • Melanoma
  • tigilanol tiglate
  • Wollstonecraft, New South Wales, Australia
  • +2 more
Oct 6, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 13, 2023

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Melanoma Trial in Salt Lake City (Nivolumab, HF10)

Terminated
Has Results
  • Melanoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 9, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Amsterdam, NH, Netherlands
    Antoni van Leeuwenhoek ziekenhuis
Feb 11, 2022

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Ipilimumab
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 11, 2022

Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)

Active, not recruiting
Has Results
  • Melanoma
  • Lymph Node Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 15, 2022

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +43 more
  • Best Practice
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Toxicity and Symptom Burden in Chronic Cancer Survivors With

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

Recruiting
  • Locally Advanced Melanoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Melanoma Stage IIIB/C Trial in Spain, Switzerland, United States (Daromun, Surgery, Adjuvant therapy)

Recruiting
  • Melanoma Stage IIIB/C
  • La Jolla, California
  • +30 more
Dec 22, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +21 more
  • Informational Intervention
  • Survey Administration
  • New Brunswick, New Jersey
  • +1 more
Apr 6, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022